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Abstract
Background: With an estimated 65 million Diabetes Mellitus (DM) patients, India ranks second in the world in
terms of DM burden. The emphasis of current medical practice has been on pharmacotherapy but, despite the best
combination therapies, acheiving glycaemic control (reduction of blood sugar to desirable levels) is a challenge.
‘Integrated Naturopathy and Yoga’(INY) is an alternative system of medicine that lays emphasis on the role of diet
and physical exercise. We assessed the short term effect of INY as an adjunct to pharmacotherapy on glycaemic
control among type 2 DM patients.
Methods: In this prospective cohort study with a 3 month follow-up, DM patients consecutively admitted to a
hospital in India from May-October 2014 for either 15 or 30 days were offered INY - a package of vegetarian diet
with no added oil, sugar and salt, yoga-based exercise, patient counselling and rest. A ‘favourable outcome’ was
defined as glycaemic control (glycosylated hemoglobin (HbA1c) < 7 % or absolute reduction by 1 %) along with at
least 50 % reduction in antidiabetes medication at 3 months relative to baseline. Compliance to diet was scored by
self-report on a scale of 0–10 and categorized into poor (0–5), moderate (6–8) and excellent (9–10).
Results: Of 101 patients with 3-month follow-up data, 65(65 %) achieved a favourable outcome – with 19(19 %)
stopping medication while sustaining glycemic control. Factors associated with favourable outcome were baseline
HbA1c and compliance to diet, which showed a significant linear relationship with mean HbA1c reductions of 0.4 %,
1.1 % and 1.7 % in relation to poor, moderate and excellent dietary compliance respectively.
Conclusion: INY, adjunctive to pharmacotherapy, was associated with a significant beneficial effect on glycaemic
control and reduced the overall need for antidiabetes medications. These early results are promising. Further
studies with long-term follow-up and using more rigorous randomized controlled trial designs are needed.
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Background
Diabetes Mellitus (DM) is a chronic condition character-
ized by increased levels of glucose in the blood and if
uncontrolled, can lead to multiple complications includ-
ing ischemic heart disease, stroke, blindness, limb ampu-
tations as well as dysfunction of nerves and kidneys. The
most common form of DM is type 2 which constitutes
more than 90 % of cases. More than 80 % of DM patients
now live in Low and Middle Income Countries (LMIC)
and the disease is being propelled by unhealthy diets and
sedentary lifestyles. The long-held myth that DM affects
only affluent countries is thus no longer true [1].
In India, there are an estimated 65 million DM pa-
tients and another 77 million in a pre-diabetic state -
India now ranks second in the world (next to China) in
terms of DM burden [1, 2]. The emphasis of current
medical practice has been on reducing the blood sugar
using drugs (akin to treating the symptoms) rather than
addressing the root causes – which are related to faulty
dietary habits, lack of exercise and lifestyle [3]. Further,
the drugs used have several known and unknown side
effects and despite combination therapies, glycaemic
control is challenging to achieve and the disease often
progresses to complications giving value to the adage,
‘once a diabetic, always a diabetic’ [4, 5]. Offering pa-
tients a structured and empowering environment to im-
plement intense lifestyle interventions, are urgently
required to foster adjunctive measures including lifestyle
changes.
‘Naturopathy and Yoga’ is an alternative form of medi-
cine that lays emphasis on the role of diet and physical
exercise in health promotion and reversal of disease. As
part of the general philosophy of ‘aligning oneself in tune
with nature’, naturopathy recommends intake of large
quantities of water (about 4–5 litres per day), vegetarian
food in its natural form including use of sprouted high-
protein pulses, fruits and vegetables, unrefined whole-
grains, with no added oil, sugar and salt, yoga-based
exercise and rest. Several studies have shown beneficial
effects of individual lifestyle interventions (including a
controlled diet), weight loss and exercise on DM man-
agement outcomes [6–11]. However, none have assessed
the effect of an integrated management approach in
achieving glycaemic control and reducing the reliance
on anti-diabetes medication.
The ‘Mantena Satyanarayana Raju Arogyalayam’
(MSRA) hospital, situated in South India offers an ‘Inte-
grated approach of Naturopathy and Yoga’ (INY) in
addition to pharmacotherapy. There is anecdotal evidence
that some DM patients following INY do not need anti-
diabetes medications anymore for maintaining their gly-
cemic control.
To date, there has been no systematic assessment of the
effect of INY, when used as adjunct to pharmacotherapy,
on glycaemic control among DM patients. Such evidence
would be useful in contemplating the role INY could play
within mainstream DM care. As a preliminary step, we
thus aimed to assess the short term effect of INY as an ad-
junct to pharmacotherapy, in achieving glycaemic control.
The specific objectives were to determine among a cohort
of type 2 DM patients enrolled into INY a) the number
(and proportion) who achieved favourable outcomes (gly-
caemic control achieved along with at-least 50 % reduc-
tion of anti-diabetic medication at 3 months after
enrolment) and b) socio-demographic and clinical factors
associated with favourable outcomes.
Methods
Ethics
Approval was received from the Ethics Advisory Group
of the International Union Against Tuberculosis and
Lung Disease, Paris, France and the Institutional Ethics
Committee of MSRA, Guntur, India. Written informed
consent was obtained from all the study participants.
Study design and period
This was a prospective cohort study involving follow-up
of type 2 DM patients for 3 months and was conducted
between March and December 2014.
Study population
All known cases of type 2 DM who were on anti-
diabetes medications (for at-least 1 year) and consecu-
tively admitted to MSRA hospital from May to August
2014 were included. The following sub-groups were ex-
cluded: children (<18 years), pregnant women, patients
with diabetes related complications related to kidney,
heart, eye, nervous system and any communicable disease
at the time of admission to MSRA. We did not exclude
any patients based on blood sugar levels at baseline.
Study setting
The Mantena Satyanarayana Raju Arogyalayam’ (MSRA)
hospital
MSRA Hospital is a 500-bedded, fully residential natur-
opathy institute located in Amaravathi city of Andhra
Pradesh, a south Indian state (population 50 million). It
is the largest naturopathy institute in India, spread
across an area of 18 acres in natural, pollution-free green
surroundings. Patients with a variety of chronic diseases
including diabetes mellitus, hypertension and cardiovas-
cular diseases seek care at the institute. People also seek
care at the institute for simple weight reduction and
general health promotion. There are ten departments
managed by around 300 trained staff including one gen-
eral physician, 14 naturopathy doctors, and 120 para-
medical workers. The institute is equipped with a yoga
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hall, a laboratory, emergency medical services, a physio-
therapy unit and facilities for naturopathy treatments.
Medical and INY management of DM
On admission, each DM patient is assessed by a quali-
fied medical doctor and his/her clinical details are re-
corded in a treatment card. The pharmacological
management (including decisions on the changing the
doses of anti-diabetic medications) is done by a diabetol-
ogist based on clinical assessment (hypoglycemic symp-
toms) and laboratory parameters (evidence of normal
FBS and PPBS).
Individuals have the option of staying for either 15 or
30 days in the institution when they learn and practice
INY under supervision of qualified doctors. The inte-
grated INY package provided to the patients included
diet, exercise, rest and relaxation and patient education
and is shown in Table 1.
After discharge, they are advised to apply the princi-
ples and practice of INY in their routine lives. At base-
line, height, weight, blood pressure, fasting plasma
glucose (FPG), post prandial plasma glucose (PPPG), gly-
cosylated haemoglobin (HbA1c), plasma sodium and
potassium levels and the details of various medications
taken by the patient are recorded. These parameters are
repeated as per individual patient needs, at the time
of discharge and at 3 months from admission. To en-
sure standardization and quality control of laboratory
procedures, all investigations were conducted at a
quality-assured laboratory called ‘Thyrocare’ (http://
www.thyrocare.com/) situated in Navi Mumbai, India.
Arrangements were made through Thyrocare blood
collection centres (available throughout the country) to
collect and transport blood specimens. While patients had
to pay for stay, food and other incidentals, costs of labora-
tory investigations were covered by the hospital.
Data collection, definition of a favorable outcome and
analysis
A pre-tested, data collection format was used to collect
information related to the study objectives. Every patient
was followed up over telephone on a monthly basis for 3
months. Phone calls were made by specially trained, in-
dependent interviewers. Study participants graded them-
selves on a scale of 0–10 (“0” for non compliance and
‘10’ for full compliance) for compliance to recommended
Table 1 Package of Integrated Naturopathy and Yoga provided at 'Manthena Sathyanarayana Raju Arogyalayam' hospital for
management of Diabetes mellitus in Andhra Pradesh, India, May-August, 2014
Component Description
Diet A special package of diet is designed for DM patients admitted in MSRA containing low glycaemic-index, fibre-rich,
plant-based diet containing whole grains, legumes, vegetables and fruits which are high in protein and no added
salt, oil and sugar. Nearly two-thirds of the diet is constituted by the foods in their natural form (not cooked) which
includes high-quality, protein-rich sprouted pulses and fruits and vegetable salads. Indian breads prepared out of
whole-wheat flour are provided instead of steamed rice as a source of carbohydrate. Special care is taken to prepare
tasty, low-calorie recipes and flavoured with locally available herbs without the use of additional salt, spices and oil.
Contrary to other reported dietary interventions in the published literature, there was no restriction in the quantity
of the food consumed by the patients, who are encouraged to eat as much as they want. A principle of ‘early dinner’
(before 7:00 pm) is followed. This is in tune with the behaviour of all diurnal animals in nature and is intended to
provide adequate rest to the body, especially the organs involved in the digestion of food. The meals (breakfast,
lunch and dinner) are provided at pre-specified times of the day to ensure that the body gets into a natural rhythm
of metabolism. Patients are also taught the methods of preparing the recipes in ‘daily cooking classes’ (1 hour) to
enable them to prepare their meals once they return home.
Exercise Regular exercise (two times a day) in the form of Yogic exercises and Pranayama (breathing exercises) are taught to
the patients who practice under the supervision of qualified yoga teachers. Emphasis is given on ‘Asanas’ (yogic
postures) which have an effect on weight reduction (especially reducing the abdominal fat stores) and stimulation
of pancreas to produce insulin. In addition, patients are encouraged to do aerobic exercises like walking, swimming
or boat-pedalling in the river.
Rest and Relaxation Several measures are taken to ensure that patients are adequately rested and live a stress-free life in the institute.
In addition to the relaxing and quiet environment of the MSRA, daily lectures are provided about stress and methods
of addressing them. Interested patients are also offered an opportunity to learn meditation and practice under
supervision of experts. Naturopathy advocates “Therapeutic Fasting” using honey, lemon and water which allows
the body to rest completely and heal itself. Patients who are able to completely stop anti-DM medications and
whose blood sugar is under control are offered an opportunity to fast for 1–3 days. Patients are carefully monitored
during this process for their blood sugar and electrolytes. In addition, several treatments such as various types of
mud/steam bath and body massages are administered to relieve pain and relieve stress.
Patient education Naturopathy emphasizes on self-responsibility of one’s own health. A minimum of 15 days of stay in the institution is
needed to understand the rationale of the intervention and for motivating the patients to practice on their own. The
emphasis is on patient empowerment to promote a sense of self-responsibility after going back to their day-to-day lives
and in the long run. There are daily lectures and discussion in the evening (60 minutes) to provide the patients an
understanding of the principles of naturopathy. There are also daily morning lectures (60 minutes) on personality
development, stress management and meditation. Videos and books about these principles are also made available to
patients. In addition, patients are counselled one-to-one by the doctors every day.
Bairy et al. BMC Complementary and Alternative Medicine  (2016) 16:290 Page 3 of 8
dietary advice and practice of yoga. There were three
questions asked on diet: How do you grade yourself on a
scale of 0–10 about eating i) sprouted pulses for break-
fast? ii) diet free of added sugar, salt and oil? iii) having
dinner before 7 pm? An average of the scores was taken
and patients were divided into three groups: poor (0–5),
moderate (6–8) and excellent (9–10). An appointment at
home was made (after consent) to collect blood samples
for laboratory analysis.
Definition of a ‘favourable outcome’: Achievement of
glycaemic control along with at-least 50 % reduction in
dose of anti-diabetes medication at 3 months relative to
baseline constituted a favourable outcome. Glycaemic
control was further defined based on HbA1c – for those
with baseline HbA1c < 7 %, maintaining it below 7 % at
3 months was considered glycaemic control and for those
with baseline HbA1c ≥ 7 %, this was defined as reducing
HbA1c at 3 months to <7 % or an absolute reduction by
1 % relative to baseline. The cut-off of 1 % was chosen
based on previous studies indicating that a drop of 1 % in
HbA1c is associated with favourable long-term cardiovas-
cular outcomes [12]. When the patient was on multiple
drugs, the reduction in dose was assessed for each drug
and averaged. Any increase in dose of existing drugs and
addition of a new drug was considered ‘unfavourable’.
Data entry was done using EpiData Entry software
(version 3.1, EpiData Association, Odense, Denmark).
Clean data along with the codebook after removing per-
sonal identifiers have been provided in additional files 1
and 2. Analysis was performed using EpiData Analysis
software (version 2.2.2.182) and STATA 12.1 (Stata Cor-
poration, Texas 77845, USA). Differences in proportions
were calculated using the chi-square test and trends were
assessed using the chi-square for linear trend. The un-
paired t-test (or kruskal wallis test) or paired t-test was
used to assess difference in means, as appropriate. Factors
independently associated with a favourable outcome were
identified using multivariate logistic regression analysis.
The level of significance was set at P ≤ 0.05.
Results
Of 223 patients enrolled, 101 could be followed up at
home at 3 months. The characteristics of individuals who
could and could not be assessed were similar (Table 2).
The reasons for not being able to reach 122 individuals at
home included unavailability of patients at the time of
scheduled contact (due to engagement in social commit-
ments, job and/or travel) and long distances from the hos-
pital making logistics for the follow-up team difficult.
Table 3 shows the socio-demographic and clinical
characteristics of those admitted and assessed at 3
months. Their median age was 55 years (Interquartile
range (IQR), 49–62) and median duration of DM was
6 years (IQR, 2.5–10). There were 40(40 %) patients who
had associated hypertension. About 85 % received oral
hypoglycemic drugs while the rest were on insulin injec-
tions. Administered drugs included metformin, glime-
peride, gliclazide, voglibose, sitagliptin, pioglitazone and
insulin. Overall 31(30 %) patients received one drug,
45(45 %) received two drugs, 18(18 %) received three
drugs and 7(7 %) received four drugs at baseline.
Glycaemic control parameters measured at baseline
and at 3 months after INY, showed significant mean re-
ductions in levels of HbA1C, FBS and PPBS - respect-
ively 0.9 %, 39 mg/dl and 36 mg/dl (P < 0.001, Table 4).
This effect was more pronounced among patients with a
baseline HbA1c of ≥7 %, with mean reductions of 1.2 %,
53 mg/dl and 53 mg/dl for HbA1c, FBS and PPBS re-
spectively. There was a dose-response relationship be-
tween compliance to dietary practices and HbA1c at 3
months with mean reductions of 0.4 %, 1.1 % and 1.7 %
among those with poor, moderate and excellent compli-
ance to dietary practices respectively (Fig. 1).
Of the 101 individuals assessed at 3 months, 65 (65 %)
had a ‘favourable outcome’ of whom, 19 stopped medica-
tion completely but sustained their HbA1c level below
7 %. Even among the 36 patients who did not meet the
definition of favourable outcome, 23 had varying reduc-
tions of HbA1c (but less than 1 %) and tapering of medi-
cations (but less than 50 %).
Significant factor associated with a favourable outcome
after adjusting for age, sex, education, baseline BMI, as-
sociated hypertension, compliance to yoga, income, dur-
ation of stay, baseline HbA1c and duration of DM was
compliance to advised diet (Table 5).
Discussion
This is the first study from India showing the adjunctive
and beneficial association of INY on glycemic control
Table 2 Demographic and clinical characteristics of patients who
could and could not be assessed at 3 months following admission
to Manthena Sathyanarayana Raju Arogyalayam (MSRA) hospital for
management of Diabetes mellitus using integrated Naturopathy
and Yoga in Andhra Pradesh, India, May-August, 2014
Characteristics Assessed Not assessed P-value
Total 101 122
Male – Number (%) 55 (55) 67 (55) 0.94
Mean age (95 % CI) 55 (53–56) 52 (50–54) 0.11*
Mean duration of DM (95 % CI) 7.6 (6–9) 7.2 (6–8) 0.61
Mean FBS (95 % CI) 149 (137–160) 148 (138–159) 0.97
Mean PPBS (95 % CI) 188 (174–202) 185 (173–198) 0.78
Mean HbA1c (95 % CI) 8.2 (7.8–8.6) 8.3 (8.0–8.6) 0.71
On oral drugs – Number (%) 86 (85) 104 (85) 0.98
DM Diabetes Mellitus, CI Confidence interval, HbA1c Glycosylated hemoglobin,
FBS Fasting blood sugar, PPBS Post Prandial Blood Sugar, CI Confidence Intervals
*Kruskal Wallis test was used
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among DM patients. INY, when provided as adjunct to
pharmacotherapy, was associated with not only achiev-
ing glycemic control in two-thirds of patients but also in
reducing by half (or more) their need for antidiabetes
medication. In about two-in-ten patients, DM medica-
tions were stopped and glycemic control was still sus-
tained. These changes are impressive when considering
the relatively short follow-up time span (3 months) and
involving a cohort with a median duration of DM of 6
years. Furthermore, these findings might indicate the be-
ginning of the process of reversal of DM and brings cau-
tious early optimism to counter the adage “once a
diabetic always a diabetic”. We would like to caution
though, that these are early results and we need to
follow-up the cohort for a longer duration to see if these
changes will be sustained and lead to overall reductions
in cardiovascular mortality.
The average reduction in HbA1c was high at 0.9 % which
is comparable to results in other studies showing the effect
of different dietary approaches on glycaemic control [6, 7,
13]. Such a significant effect could be related to the inte-
grated approach implemented within a structured and en-
abling environment and involving multiple interventions
that fostered lifestyle changes, each of which have been
shown to be beneficial in previous studies [6, 7, 14–16].
The proportion of favourable outcomes were similar
across the subgroups of patients and the only two asso-
ciated significant factors were baseline HbA1c and com-
pliance to diet. This indicates that INY could be equally
effective irrespective of duration of DM, type of medica-
tions, age, sex, education, income, or hypertension.
Compliance to diet showed a highly significant dose re-
sponse relationship underlining its importance in achiev-
ing glycemic control. This maybe attributed to the many
unique features of the naturopathy diet in comparison
with other recommended dietary approaches - natural
foods with no added oil, salt and sugar and no restric-
tion in quantity of food intake.
The exact mechanism of action of INY in improving
glycaemic control is not known. We speculate a few pos-
sible mechanisms. Previous studies have shown that
weight loss is associated with glycaemic control [9]. A
couple of studies on reversal of DM have been mostly
among obese individuals who underwent surgical inter-
ventions (like gastric bypass surgery and other bariatric
Table 3 Socio-demographic and clinical characteristics of
individuals admitted to Manthena Sathyanarayana Raju
Arogyalayam (MSRA) hospital for management of Diabetes
mellitus using integrated Naturopathy and Yoga in Andhra
Pradesh, India, May-August, 2014
Category Sub-category N (%)
Total 101 (100)
Age (years) <60 66 (65)
≥60 35 (35)
Sex Male 55 (55)
Female 46 (45)
Occupation Housewife 40 (40)
Retired 20 (20)
Self-employed (business) 19 (19)
Government employee 12 (12)
Private employee 7 (7)
Unemployed 3 (3)
Education (years in school) <12 50 (50)
≥12 51 (51)
Associated Hypertension No 61 (60)
Yes 40 (40)
Family income/annum <4000 USD 52 (51)
≥4000 USD 49 (49)
History of tobacco smoking Current smoker 4 (4)
Past smoker 5 (5)
Never smoker 92 (91)
History of alcohol intake Current drinker 8 (8)
Past drinker 6 (6)
Never drank 87 (86)




Diabetic medication Oral 86 (85)
Insulin alone or with oral 15 (15)
USD United States Dollar; Current smoker: history of smoking tobacco in the
past 1 month
Current drinker: history of consuming alcohol in the past 1 month
Table 4 Effect of Integrated Naturopathy and Yoga management on glycaemic control (baseline and 3 months) among type 2
Diabetes patients admitted to Manthena Sathyanarayana Raju Arogyalayam (MSRA) hospital, Andhra Pradesh, India, May-August, 2014
Glycaemic control parameter Mean baseline level Mean level at 3 months Mean difference (95 % CI) p-value
HbA1C (%) 8.2 7.3 0.9 (0.6–1.2) <0.001
FBS (mg/dl) 149 109 39 (27–52) <0.001
PPBS (mg/dl) 188 152 36 (23–49) <0.001
CI Confidence interval, HbA1C Glycosylated hemoglobin, FBS Fasting blood sugar, PPBS Post Prandial Blood Sugar, mg/dl milligram per deciliter
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procedures) and was associated with sudden weight loss
[17]. Some studies have associated low-fat vegan diets to
reduction of intra myocelluar lipids, pancreatic and hep-
atic triacyl glycerols thus reversing insulin resistance and
restoring beta cell function [9, 18, 19]. Given that INY
diet does not use any added oils for cooking, this could
be a possible mechanism. This merits further study.
There were several strengths to the study. First, INY
was provided in a structured and enabling environment
under supervision of qualified doctors and counsellors.
This might have fostered lifestyle behaviour change - one
of the most challenging things to achieve. Second, out-
come was assessed using HbA1c which provides the most
reliable assessment of glycaemic control as it is less sus-
ceptible to temporary swings in blood sugar. Third, collec-
tion and analysis of laboratory tests were standardized and
quality-controlled. Fourth, we were rather strict in defin-
ing the principal outcome measure which included not
only achievement of glycemic control (which is the stand-
ard practice) but also a simulataneous and substantial re-
duction of DM medication by at least half from baseline
doses. If such a strict threshold was not used and consid-
ered any reduction in medication and/or any reduction in
HbA1c as favourable, then the proportion with favourable
outcome would have been even higher.
This study has several implications for policy and
practice. First, it highlights the important adjunctive role
for alternative medicine in improving glycaemic control
and the quality of life [13, 20, 21]. There are also likely
cost saving benefits for patients and health systems –
direct costs arising from drugs and management of com-
plications and indirect costs from loss of productivity.
Given the massive economic burden posed by DM on
global health care expenditure [1], approaches such as
INY need to be considered. Future studies should exam-
ine the cost-effectiveness of this approach.
Second, even though the value of lifestyle interven-
tions are acknowledged widely, in practice they prove to
be difficult to implement. In this light, INY brings a
sense of optimism with nearly 80 % of patients showing
moderate to excellent dietary compliance. While the role
of pharmacotherapy remains important, this study em-
phasizes the need for lifestyle changes. Clinicians often
feel ill-informed about providing lifestyle advice and may
lack time and capacity to take on this role [22, 23]. A
possible way forward is to make DM care interdisciplin-
ary with specialists from various systems of medicine
working together as a team – allopathic doctors taking
care of pharmacological management while delegating
the responsibility of intense lifestyle interventions to al-
ternative systems of medicine. The latter are often better
versed to handle such aspects [21, 24].
We had some study limitations. Nearly half of the co-
hort could not be contacted for follow-up investigation
at 3 months and this might have introduced responder
bias. However, the baseline characteristics of responders
and non-responders were similar especially duration of
DM and baseline values of HbA1c, FBG and PPBG, pos-
sibly suggesting that the results can be generalised to the
entire cohort. Also the patients had to be followed up at
home and those excluded were due to logistic con-
straints in reaching them and does not reflect health
seeking behaviour. Importantly this assessment involved
a short follow-up period of 3 months and one wonders
if patients will continue to be compliant to INY in the
longer term and if favorable effects can be sustained. This
Fig. 1 Dose response relationship between self-reported dietary compliance and mean reduction in HbA1c at 3 months relative to baseline
among type 2 DM patients admitted for Integrated Naturopathy and Yoga management to the Manthena Sathyanarayana Raju Arogyalayam (MSRA)
hospital, Andhra Pradesh, India, May-August, 2014
Bairy et al. BMC Complementary and Alternative Medicine  (2016) 16:290 Page 6 of 8
is currently being studied in our setting and cohort studies
with longer-term follow-up will enlighten us. Another
limitation relates to the fact that this was a single arm
study with no comparison group. Ideally a Randomized
Controlled Trial would have provided the most robust evi-
dence possible. However, since the patients coming to
MSRA hospital want to undergo lifestyle intervention on
their self-will, it will be challenging and arguably unethical
to implement a randomized controlled trial. Finally, it is
probable that patients who visited our hospital and partici-
pated in the study were more likely to be health-conscious
and INY compliant than the general population. A
qualitative study has shown that patients on DM medica-
tion get tired of side effects and long-term DM complica-
tions making them opt for naturopathy [21]. Alternative
approaches such as INY may thus have higher patient ac-
ceptability in the longer run [13].
Conclusions
In conclusion, INY, when used as adjunct to pharmaco-
therapy, was associated with achievingglycaemic control in
type 2 DM patients and reducing the overall need for anti-
diabetes medications within a relatively short span of time.
We need to conduct longer-term studies using more
Table 5 Factors associated with a favourable management outcome (at 3 months) among patients admitted for Integrated Naturopathy
and Yoga management to the Manthena Sathyanarayana Raju Arogyalayam (MSRA) hospital, Andhra Pradesh, India, May-August, 2014
Category Subcategory Total Favourable outcome n (%) aOR (95 % CI) p-value
Total 101 65
Age group (years) <60 66 44 (67) 1.0
≥60 35 22 (63) 0.5 (0.1–1.7) 0.29
Sex Male 55 40 (73) 1.0
Female 46 26 (57) 0.4 (0.1–1.4) 0.15
Education (years in school) <12 50 30 (60) 0.9 (0.3–2.7) 0.87
≥12 51 36 (71) 1.0
Hypertension No 61 37 (61) 1.0
Yes 40 29 (73) 1.5 (0.5–4.4) 0.50
Family income/annum <4000 USD 52 32 (62) 1.0
≥4000 USD 49 34 (69) 1.4 (0.5–4.2) 0.52
Duration of diabetes (Years) 1–2 25 20 (80) 1.0
3–5 24 13 (54) 0.2 (0.1–1.2) 0.07
6–9 19 11 (58) 0.3 (0.1–1.7) 0.16
≥10 33 22 (67) 0.6 (0.1–4.4) 0.62
Diabetic medication Oral 86 57 (66) 1.0
Insulin 15 9 (60) 0.9 (0.2–4.2) 0.94
BMI (kg/m2) <25 23 15 (65) 1.5 (0.4–6.6) 0.62
25.0–29.9 43 30 (70) 1.8 (0.4–8.7) 0.45
30.0 and above 34 20 (59) 1.0
Duration of stay 15 days 81 53 (66) 1.0
30 days 20 13 (65) 0.8 (0.2–3.9) 0.81
Baseline HbA1c <7 % 28 23 (82) 1.0
≥7 % 73 43 (59) 0.4 (0.1–1.4) 0.14
Compliance to advised dieta Poor 19 7 (37) 1.0
Moderate 32 19 (59) 3.8 (0.7–20.6) 0.12
Excellent 49 40 (82) 16.5 (3.0–91.0) 0.001b
Compliance to Yogaa Poor 27 16 (59) 1.0
Moderate 23 17 (74) 1.2 (0.2–7.0) 0.84
Excellent 50 33 (66) 0.5 (0.1–2.1) 0.32
USD United States Dollars, BMI Body Mass Index, HbA1c Glycosylated hemoglobin, aOR adjusted Odds Ratio, CI Confidence Intervals
aPoor: score of 0–5; Moderate: score of 6–8; Excellent: score of 9–10
bChi-square for linear trend = 12.1, P <0.001
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rigorous randomized controlled trial designs to confirm
these results.
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